344
Participants
Start Date
August 1, 2011
Primary Completion Date
June 5, 2020
Study Completion Date
June 5, 2020
Octagam IVIG 5% or 10%
Octagam IVIG 5% or 10%
Panzyga
Panzyga
Octapharma Research Site, Vienna
Octapharma Research Site, Salzburg
Octapharma Research Site, Marseille
Octapharma Research Location, Marseille
Octapharma Research Site, Marseille
Octapharma Research Center, Marseille
Octapharma Research Location, Caen
Octapharma Research Site, Caen
Octapharma Research Site, La Rochelle
Octapharma Research Site, Bourges
Octapharma Research Site, Madrid
Octapharma Research Location, Madrid
Octapharma Research Site, Madrid
Octapharma Research Site, Madrid
Octapharma Research Site, Toulouse
Octapharma Research Site, Pessac
Octapharma Research Site, Béziers
Octapharma Research Site, Rennes
Octapharma Research Site, Nantes
Octapharma Research Site, Nevers
Octapharma Research Site, Pierre-Bénite
Octapharma Research Site, Montauban
Octapharma Research Site, Argenteuil
Octapharma Research Site, Gmunden
Octapharma Research Site, Graz
Octapharma Research Site, Klagenfurt
Octapharma Research Site, Oberndorf
St. Paul's Hospital, Vancouver
Health Sciences Centre, Winnipeg
Hamilton Health Sciences, Hamilton
St. Michael's Hospital, Toronto
Hospital for Sick Children, Toronto
Octapharma Research Site, Barcelona
Octapharma Research Site, Leeds
Octapharma Research Site, London
Octapharma Research Site, London
Octapharma Research Site, Plymouth
Octapharma Research Site, Stafford
Lead Sponsor
Octapharma
INDUSTRY